{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:22:45Z","timestamp":1790270565877,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T00:00:00Z","timestamp":1556496000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00535-019-01588-4","type":"journal-article","created":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T17:39:14Z","timestamp":1556559554000},"page":"972-983","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Efficacy and safety of hangeshashinto for treatment of GERD refractory to proton pump inhibitors"],"prefix":"10.1007","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1233-0977","authenticated-orcid":false,"given":"Toshihisa","family":"Takeuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Hongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuguhiro","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuyuki","family":"Murano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhide","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,29]]},"reference":[{"key":"1588_CR1","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","volume":"101","author":"N Vakil","year":"2006","unstructured":"Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900\u201320.","journal-title":"Am J Gastroenterol"},{"key":"1588_CR2","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00535-016-1227-8","volume":"51","author":"K Iwakiri","year":"2016","unstructured":"Iwakiri K, Kinoshita Y, Habu Y, et al. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015. J Gastroenterol. 2016;51:751\u201367.","journal-title":"J Gastroenterol"},{"key":"1588_CR3","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00535-009-0047-5","volume":"44","author":"Y Fujiwara","year":"2009","unstructured":"Fujiwara Y, Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol. 2009;44:518\u201334.","journal-title":"J Gastroenterol"},{"key":"1588_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1365-2036.2005.02531.x","volume":"22","author":"R Fass","year":"2005","unstructured":"Fass R, Shapiro M, Dekel R, et al. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease\u2014where next? Aliment Pharmacol Ther. 2005;22:79\u201394.","journal-title":"Aliment Pharmacol Ther"},{"key":"1588_CR5","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1007\/s00535-009-0070-6","volume":"44","author":"K Iwakiri","year":"2009","unstructured":"Iwakiri K, Kawami N, Sano H, et al. Acid and non-acid reflux in Japanese patients with non-erosive reflux disease with persistent reflux symptoms, despite taking a double-dose of proton pump inhibitor: a study using combined pH-impedance monitoring. J Gastroenterol. 2009;44:708\u201312.","journal-title":"J Gastroenterol"},{"key":"1588_CR6","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1007\/s00535-013-0896-9","volume":"49","author":"K Tominaga","year":"2014","unstructured":"G-PRIDE Study Group, Tominaga K, Kato M, et al. A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study. J Gastroenterol. 2014;49:1392\u2013405.","journal-title":"J Gastroenterol"},{"key":"1588_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1471-230X-14-116","volume":"14","author":"Y Sakata","year":"2014","unstructured":"Sakata Y, Tominaga K, Kato M, et al. Clinical characteristics of elderly patients with proton pump inhibitor-refractory non-erosive reflux disease from the G-PRIDE study who responded to rikkunshito. BMC Gastroenterol. 2014;14:116.","journal-title":"BMC Gastroenterol"},{"key":"1588_CR8","first-page":"2533","volume":"13","author":"S Harasawa","year":"1993","unstructured":"Harasawa S, Miwa T. The efficacy of Hangeshashinto on gastric motility disorders. Prog Med. 1993;13:2533\u20139 (Japanese).","journal-title":"Prog Med"},{"key":"1588_CR9","doi-asserted-by":"publisher","first-page":"961","DOI":"10.5833\/jjgs.28.961","volume":"28","author":"A Gochi","year":"1995","unstructured":"Gochi A, Hirose S, Sato K, et al. The effect of Hange-shashin-to and Rikkunshi-to against the digestive symptoms after gastrectomy. Jpn J Gastroenterol Surg. 1995;28:961\u20135 (Japanese).","journal-title":"Jpn J Gastroenterol Surg"},{"key":"1588_CR10","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s00280-014-2440-x","volume":"73","author":"T Aoyama","year":"2014","unstructured":"Aoyama T, Nishikawa K, Takiguchi N, et al. Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis. Cancer Chemother Pharmacol. 2014;73:1047\u201354.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1588_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00280-015-2767-y","volume":"76","author":"C Matsuda","year":"2015","unstructured":"Matsuda C, Munemoto Y, Mishima H, et al. Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis. Cancer Chemother Pharmacol. 2015;76:97\u2013103.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1588_CR12","first-page":"581","volume":"42","author":"O Yamaguchi","year":"2015","unstructured":"Yamaguchi O, Kawashima A, Shiono A, et al. Hange-Shashin-to for preventing diarrhea during afatinib therapy. Gan To Kagaku Ryoho. 2015;42:581\u20133 (Japanese).","journal-title":"Gan To Kagaku Ryoho"},{"key":"1588_CR13","first-page":"2364","volume":"42","author":"N Hoshi","year":"2015","unstructured":"Hoshi N, Kofunato Y, Yashima R, et al. Treating side effects of FOLFIRINOX\u2013a study of the effect of Hange-shashin-to on preventing diarrhea. Gan To Kagaku Ryoho. 2015;42:2364\u20136 (Japanese).","journal-title":"Gan To Kagaku Ryoho"},{"key":"1588_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/512947","volume":"2015","author":"H Fukamachi","year":"2015","unstructured":"Fukamachi H, Matsumoto C, Omiya Y, et al. Effects of Hangeshashinto on growth of oral microorganisms. Evid Based Complement Altern Med. 2015;2015:1\u20136.","journal-title":"Evid Based Complement Altern Med"},{"key":"1588_CR15","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1248\/bpb.20.954","volume":"20","author":"Y Kase","year":"1997","unstructured":"Kase Y, Hayakawa T, Ishige A, et al. The Effects of Hange-shashin-to on the content of prostaglandin E2 and water absorption in the large intestine of rats. Biol Pharm Bull. 1997;20:954\u20137.","journal-title":"Biol Pharm Bull"},{"key":"1588_CR16","doi-asserted-by":"publisher","first-page":"S478","DOI":"10.1016\/S0016-5085(16)31648-1","volume":"150","author":"T Takeuchi","year":"2016","unstructured":"Takeuchi T, Kawaguchi S, Takahashi Y, et al. Su1132 efficacy of Hange-shashinto on gastrointestinal symptoms in patients with gastroesophageal reflux disease refractory to proton pump inhibitor therapy. Gastroenterology. 2016;150:S478.","journal-title":"Gastroenterology"},{"key":"1588_CR17","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s00535-004-1417-7","volume":"39","author":"M Kusano","year":"2004","unstructured":"Kusano M, Shimoyama Y, Sugimoto S, et al. Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol. 2004;39:888\u201391.","journal-title":"J Gastroenterol"},{"key":"1588_CR18","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s10620-006-9674-3","volume":"52","author":"M Kusano","year":"2007","unstructured":"Kusano M, Shimoyama Y, Kawamura O, et al. Proton pump inhibitors improve acid-related dyspepsia in gastroesophageal reflux disease patients. Dig Dis Sci. 2007;52:1673\u20137.","journal-title":"Dig Dis Sci"},{"key":"1588_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/BF01535722","volume":"33","author":"J Svedlund","year":"1988","unstructured":"Svedlund J, Sj\u00f6din I, Dotevall G. GSRS\u2014a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33:129\u201334.","journal-title":"Dig Dis Sci"},{"key":"1588_CR20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s00535-011-0488-5","volume":"47","author":"K Tominaga","year":"2012","unstructured":"Tominaga K, Iwakiri R, Fujimoto K, et al. Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan. J Gastroenterol. 2012;47:284\u201392.","journal-title":"J Gastroenterol"},{"key":"1588_CR21","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s10620-018-4927-5","volume":"63","author":"G Domingues","year":"2018","unstructured":"Domingues G, Moraes-Filho JPP, Fass R. Refractory heartburn: a challenging problem in clinical practice. Dig Dis Sci. 2018;63:577\u201382.","journal-title":"Dig Dis Sci"},{"key":"1588_CR22","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.3748\/wjg.v19.i39.6523","volume":"19","author":"A Altomare","year":"2013","unstructured":"Altomare A, Guarino MP, Cocca S, et al. Gastroesophageal reflux disease: update on inflammation and symptom perception. World J Gastroenterol. 2013;19:6523\u20138.","journal-title":"World J Gastroenterol"},{"key":"1588_CR23","doi-asserted-by":"publisher","first-page":"G568","DOI":"10.1152\/ajpgi.00276.2012","volume":"304","author":"T Kondo","year":"2013","unstructured":"Kondo T, Oshima T, Tomita T, et al. Prostaglandin E 2 mediates acid-induced heartburn in healthy volunteers. Am J Physiol-Gastrointest Liver Physiol. 2013;304:G568\u201373.","journal-title":"Am J Physiol-Gastrointest Liver Physiol"},{"issue":"1249\u20131255","key":"1588_CR24","first-page":"e1","volume":"13","author":"T Kondo","year":"2015","unstructured":"Kondo T, Oshima T, Tomita T, et al. The nonsteroidal anti-inflammatory drug diclofenac reduces acid-induced heartburn symptoms in healthy volunteers. Clin Gastroenterol Hepatol. 2015;13(1249\u20131255):e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1588_CR25","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00535-017-1308-3","volume":"52","author":"T Kondo","year":"2017","unstructured":"Kondo T, Sei H, Yamasaki T, et al. A novel prostanoid EP1 receptor antagonist, ONO-8539, reduces acid-induced heartburn symptoms in healthy male volunteers: a randomized clinical trial. J Gastroenterol. 2017;52:1081\u20139.","journal-title":"J Gastroenterol"},{"key":"1588_CR26","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1177\/1534735413520035","volume":"13","author":"T Kono","year":"2014","unstructured":"Kono T, Kaneko A, Matsumoto C, et al. Multitargeted effects of hangeshashinto for treatment of chemotherapy-induced oral mucositis on inducible prostaglandin e2 production in human oral keratinocytes. Integr Cancer Ther. 2014;13:435\u201345.","journal-title":"Integr Cancer Ther"},{"key":"1588_CR27","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s00280-006-0187-8","volume":"58","author":"K Takasuna","year":"2006","unstructured":"Takasuna K, Hagiwara T, Watanabe K, et al. Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea. Cancer Chemother Pharmacol. 2006;58:494\u2013503.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1588_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.surg.2018.02.003","volume":"164","author":"T Miyashita","year":"2018","unstructured":"Miyashita T, Kono T, Matsui D, et al. Preventive effect of oral hangeshashinto (TJ-14) on the development of reflux-induced esophageal cancer. Surgery. 2018;164:49\u201355.","journal-title":"Surgery"},{"key":"1588_CR29","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1001\/jamainternmed.2015.7927","volume":"176","author":"AJ Schoenfeld","year":"2016","unstructured":"Schoenfeld AJ, Grady D. Adverse effects associated with proton pump inhibitors. JAMA Intern Med. 2016;176:172.","journal-title":"JAMA Intern Med"},{"key":"1588_CR30","first-page":"477","volume":"113","author":"J M\u00f6ssner","year":"2016","unstructured":"M\u00f6ssner J. The indications, applications, and risks of proton pump inhibitors. Dtsch Arztebl Int. 2016;113:477.","journal-title":"Dtsch Arztebl Int"},{"key":"1588_CR31","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1001\/jama.2016.5657","volume":"315","author":"KB Dunbar","year":"2016","unstructured":"Dunbar KB, Agoston AT, Odze RD, et al. Association of acute gastroesophageal reflux disease with esophageal histologic changes. JAMA. 2016;315:2104\u201312.","journal-title":"JAMA"},{"key":"1588_CR32","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.3748\/wjg.v20.i9.2412","volume":"20","author":"LH Ren","year":"2014","unstructured":"Ren LH, Chen WX, Qian LJ, et al. Addition of prokinetics to PPI therapy in gastroesophageal reflux disease: a meta-analysis. World J Gastroenterol. 2014;20:2412\u20139.","journal-title":"World J Gastroenterol"},{"key":"1588_CR33","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2036.2010.04517.x","volume":"33","author":"H Miwa","year":"2011","unstructured":"Miwa H, Inoue K, Ashida K, et al. Randomised clinical trial: efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease\u2014a double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2011;33:323\u201332.","journal-title":"Aliment Pharmacol Ther"},{"key":"1588_CR34","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/jgh.13970","volume":"33","author":"T Takeuchi","year":"2018","unstructured":"Takeuchi T, Takahashi Y, Kawaguchi S, et al. Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump inhibitor: acotiamide plus usual-dose proton pump inhibitor versus double-dose proton pump inhibitor: Therapy of GERD and FD overlaps. J Gastroenterol Hepatol. 2018;33:623\u201330.","journal-title":"J Gastroenterol Hepatol"},{"key":"1588_CR35","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/apt.13394","volume":"42","author":"SL Shah","year":"2015","unstructured":"Shah SL, Lacy BE, DiBaise JK, et al. The impact of obesity on oesophageal acid exposure time on and off proton pump inhibitor therapy. Aliment Pharmacol Ther. 2015;42:1093\u2013100.","journal-title":"Aliment Pharmacol Ther"},{"key":"1588_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1479-8301.2010.00347.x","volume":"11","author":"Y Utumi","year":"2011","unstructured":"Utumi Y, Iseki E, Murayama N, et al. Effect of Rikkunshi-to on appetite loss found in elderly dementia patients: a preliminary study: rikkunshi-to and elderly dementia patients. Psychogeriatrics. 2011;11:34\u20139.","journal-title":"Psychogeriatrics"},{"key":"1588_CR37","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1111\/j.1368-5031.2005.00639.x","volume":"59","author":"A Pilotto","year":"2005","unstructured":"Pilotto A, Franceschi M, Paris F. Recent advances in the treatment of GERD in the elderly: focus on proton pump inhibitors: treatment of GERD in the elderly. Int J Clin Pract. 2005;59:1204\u20139.","journal-title":"Int J Clin Pract"},{"key":"1588_CR38","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3937\/kampomed.68.377","volume":"68","author":"N Mantani","year":"2017","unstructured":"Mantani N, Oka H, Watanabe T, et al. Incidence of liver injury related to kampo medicine containing Scutellaria baicalensis at our clinic. Kampo Med. 2017;68:377\u201381 (Japanese).","journal-title":"Kampo Med"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-019-01588-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-019-01588-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-019-01588-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T23:23:14Z","timestamp":1588029794000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-019-01588-4"}},"subtitle":["Usual dose proton pump inhibitors plus hangeshashinto versus double-dose proton pump inhibitors: randomized, multicenter open label exploratory study"],"short-title":[],"issued":{"date-parts":[[2019,4,29]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["1588"],"URL":"https:\/\/doi.org\/10.1007\/s00535-019-01588-4","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,29]]},"assertion":[{"value":"13 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Kazuhide Higuchi has received honoraria from Tsumura Co,. Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}